Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors

[Display omitted] •Aminoadamantane and monoterpene hybrids are good inhibitors of Tdp1.•The most promising inhibitor was synthesized from 1-aminoadamantane and citronellal.•The inhibitor enhanced cytotoxicity of topotecan against colon carcinoma HCT-116.•The inhibitor proved to have low own cytotoxi...

Full description

Saved in:
Bibliographic Details
Published inBioorganic chemistry Vol. 76; pp. 392 - 399
Main Authors Ponomarev, Konstantin Yu, Suslov, Evgeniy V., Zakharenko, Alexandra L., Zakharova, Olga D., Rogachev, Artem D., Korchagina, Dina V., Zafar, Ayesha, Reynisson, Jóhannes, Nefedov, Andrey A., Volcho, Konstantin P., Salakhutdinov, Nariman F., Lavrik, Olga I.
Format Journal Article
LanguageEnglish
Published SAN DIEGO Elsevier Inc 01.02.2018
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] •Aminoadamantane and monoterpene hybrids are good inhibitors of Tdp1.•The most promising inhibitor was synthesized from 1-aminoadamantane and citronellal.•The inhibitor enhanced cytotoxicity of topotecan against colon carcinoma HCT-116.•The inhibitor proved to have low own cytotoxicity. The ability of a number of nitrogen-containing compounds that simultaneously carry the adamantane and monoterpene moieties to inhibit Tdp1, an important enzyme of the DNA repair system, is studied. Inhibition of this enzyme has the potential to overcome chemotherapeutic resistance of some tumor types. Compound (+)-3c synthesized from 1-aminoadamantane and (+)-myrtenal, and compound 4a produced from 2-aminoadamantane and citronellal were found to be most potent as they inhibited Tdp1 with IC50 values of 6 and 3.5 µM, respectively. These compounds proved to have low cytotoxicity in colon HCT-116 and lung A-549 human tumor cell lines (CC50 > 50 µM). It was demonstrated that compound 4a at 10 µM enhanced cytotoxicity of topotecan, a topoisomerase 1 poison in clinical use, against HCT-116 more than fivefold and to a lesser extent of 1.5 increase in potency for A-549.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0045-2068
1090-2120
1090-2120
DOI:10.1016/j.bioorg.2017.12.005